Our study identifies MARCH8 as a new tumor suppressor in inhibiting breast cancer metastasis and enhancing cancer cell death, partially via the lysosomal degradation of the breast cancer stem-cell marker CD44, as well as via the proteosome-dependent degradation of STAT3. This evidence concerns the gene CD44 and breast cancer.